TY - JOUR
T1 - Survival following the development of ascites and/or peripheral oedema in primary biliary cirrhosis
T2 - A staged prognostic model
AU - Chan, Chun Wing
AU - Carpenter, James R.
AU - Rigamonti, Cristina
AU - Gunsar, Fulya
AU - Burroughs, Andrew K.
N1 - Funding Information:
James Carpenter is supported by ESRC research grant ‘‘Missing data methodology for multilevel models’’.
PY - 2005/9
Y1 - 2005/9
N2 - Objective. Current prognostic models in primary biliary cirrhosis (PBC) have low precision, partly due to the restricted inclusion criteria of some cohorts used for modelling but also because of the prolonged natural course of the disease. It is hypothesized that better precision could be achieved with a staged model, using ascites or peripheral oedema as a new starting-point for prediction. Material and methods. The study was based on an established database of 289 consecutive patients, followed between 1977 and 1998. Stepwise Cox regression was used to construct a staged model based on 143 patients who first developed ascites (n = 111) or peripheral oedema (n = 32) at entry or during subsequent follow-up. The model was compared with published models using graphical methods and receiver operating characteristics (ROCs). Results. Mean time from clinical diagnosis of ascites or peripheral oedema to death was 3.1 years. The following variables had independent prognostic significance: log 10(bilirubin) (p <0.001), albumin (p <0.001), age (p <0.001) and history of encephalopathy (p <0.001). Goodness of fit showed that the survival probabilities predicted by the Ascites Stage Model fitted well with the observed data. The Ascites Stage Model (ROC 0.8324 (SE 0.0348)) was a better predictor of survival than the Mayo long-term model (ROC 0.7833 (SE 0.0397)), the Mayo Repeated Patient Visits Model (ROC 0.7779 (SE 0.0399)) and the Royal Free PBC Prognostic Model (ROC 0.7785 (SE 0.0396)). Conclusions. The Ascites Stage Model gives a better survival estimate for PBC patients once they have developed ascites or peripheral oedema compared with the current models, and demonstrates an advantage of staged models in diseases with a prolonged natural history.
AB - Objective. Current prognostic models in primary biliary cirrhosis (PBC) have low precision, partly due to the restricted inclusion criteria of some cohorts used for modelling but also because of the prolonged natural course of the disease. It is hypothesized that better precision could be achieved with a staged model, using ascites or peripheral oedema as a new starting-point for prediction. Material and methods. The study was based on an established database of 289 consecutive patients, followed between 1977 and 1998. Stepwise Cox regression was used to construct a staged model based on 143 patients who first developed ascites (n = 111) or peripheral oedema (n = 32) at entry or during subsequent follow-up. The model was compared with published models using graphical methods and receiver operating characteristics (ROCs). Results. Mean time from clinical diagnosis of ascites or peripheral oedema to death was 3.1 years. The following variables had independent prognostic significance: log 10(bilirubin) (p <0.001), albumin (p <0.001), age (p <0.001) and history of encephalopathy (p <0.001). Goodness of fit showed that the survival probabilities predicted by the Ascites Stage Model fitted well with the observed data. The Ascites Stage Model (ROC 0.8324 (SE 0.0348)) was a better predictor of survival than the Mayo long-term model (ROC 0.7833 (SE 0.0397)), the Mayo Repeated Patient Visits Model (ROC 0.7779 (SE 0.0399)) and the Royal Free PBC Prognostic Model (ROC 0.7785 (SE 0.0396)). Conclusions. The Ascites Stage Model gives a better survival estimate for PBC patients once they have developed ascites or peripheral oedema compared with the current models, and demonstrates an advantage of staged models in diseases with a prolonged natural history.
KW - Fluid retention
KW - Liver transplantation
KW - Primary biliary cirrhosis
KW - Prognostic score
UR - http://www.scopus.com/inward/record.url?scp=24744431630&partnerID=8YFLogxK
U2 - 10.1080/00365520510023215
DO - 10.1080/00365520510023215
M3 - Article
SN - 0036-5521
VL - 40
SP - 1081
EP - 1089
JO - Scandinavian Journal of Gastroenterology
JF - Scandinavian Journal of Gastroenterology
IS - 9
ER -